Navigation Links
Tumor microvesicles reveal detailed genetic information
Date:2/10/2011

The Massachusetts General Hospital (MGH) research team that first discovered tumor-associated RNA in tiny membrane-enclosed sacs released into the bloodstream by cancer cells has now found that these microvesicles also contain segments of tumor DNA, including retrotransposons also called "jumping genes" that copy and insert themselves into other areas of the genome. The investigators' report, which has been published in Nature Communications, is the first to show that microvesicles are involved in transferring retrotransposons between cells.

"Retrotransposons' action of self-copying and reinserting themselves into the genome leads to genetic instability," says Johan Skog, PhD, who led the current study while an investigator in the MGH Neurology Service. "Many researchers have proposed this as a mechanism for genetic diversity and for evolution. Retrotransposons are known to be upregulated in cancer, and discovering them in microvesicles that can be found in all body fluids suggests they could be useful biomarkers to help understand tumor progression and monitor treatment response."

Skog was lead author of a 2008 study that first identified tumor-associated RNA in microvesicles, also called exosomes, released by the deadly adult brain tumor glioblastoma. To further investigate the ability of microvesicles to reflect the genetic status of tumors, in the current study the MGH team analyzed the nucleic acid contents of microvesicles from glioblastomas, from two types of pediatric brain tumors, and from malignant melanomas.

They found that the microvesicles contained tumor DNA as well as RNA and that microvesicles from one of the pediatric tumors studied had elevated levels of both DNA and RNA from the oncogene c-Myc, which correlated with the gene's expression in that tumor. "We showed that amplification of c-Myc was present in microvesicles whenever it was present in the donor cell and that microvesicle analysis can reveal oncogene expression in the original tumor," explains Leonora Balaj of MGH Neurology, the first author of the study.

High levels of retrotransposon-associated RNA sequences were also detected in tumor microvesicles, and the investigators found those microvesicles could transfer their contents into normal cells. "One of the most important functions of tumor-derived microvesicles may be modification of normal cells in the microenvironment to make them more supportive of tumor growth," says study co-author Xandra Breakefield, PhD, MGH Neurology and a professor of Neurology at Harvard Medical School.


'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Related biology news :

1. Childrens National researchers develop novel anti-tumor vaccine
2. A link between mitochondria and tumor formation in stem cells
3. Design of a compound that stabilizes the main natural suppressor of tumors
4. Researchers identify Achilles heel of common childhood tumor
5. Purple tomatoes: The richness of antioxidants against tumors
6. Jefferson Department of Surgery announces new pancreas tumor registry
7. Two new compounds show promise for eliminating breast cancer tumors
8. 2 new compounds show promise for eliminating breast cancer tumors
9. Novel technique for fluorescence tomography of tumors in living animals
10. Researchers identify new anti-tumor gene
11. UC Davis researchers find molecule that targets brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... , July 20, 2017 Delta (NYSE: DAL ... board any Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to ... Delta,s biometric ... Sky Club is now integrated into the boarding process to allow ...
(Date:6/14/2017)... , June 15, 2017  IBM (NYSE: IBM ) ... international tech event dedicated to developing collaboration between startups and ... on June 15-17. During the event, nine startups will showcase ... value in various industries. France ... the international market, with a 30 percent increase in the ...
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
Breaking Biology News(10 mins):
(Date:8/11/2017)... ROCKVILLE, Md. , Aug. 11, 2017 ... in a New York Times article regarding ... 9.2 billion, according to Kalorama Information.  The ... an App for That"  used information ... Remote Patient Monitoring & Telemedicine Market  (Sleep, ...
(Date:8/10/2017)... (PRWEB) , ... August 09, 2017 , ... ... to help the agriculture industry reach its ideal customers with the right message. ... nation. , “As a Midwest company, we realize how crucial the agriculture industry ...
(Date:8/10/2017)... ... , ... Okyanos Center for Regenerative Medicine has announced its First Annual ... Grand Bahama on September 27, 2017. This daytime event is free to attend, however ... of Health’s National Stem Cell Ethics Committee (NSCEC) and regulations laid out in the ...
(Date:8/10/2017)... ... August 10, 2017 , ... CNA ... outlet had initiated coverage on Next Group Holdings, Inc. and see's significant opportunity ... geared toward those that cannot engage in traditional banking services. According to industry ...
Breaking Biology Technology: